Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Prodrugs01:30

Prodrugs

3.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
3.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Revisiting 2-Substituted-4(1<i>H</i>)-Quinolones for Targeting the <i>Plasmodium falciparum</i> Cytochrome bc<sub>1</sub> Complex.

Journal of medicinal chemistry·2026
Same author

A widespread internal brain state for fentanyl withdrawal.

bioRxiv : the preprint server for biology·2026
Same author

Furoxan derivatives with antimalarial activity that disrupt P. falciparum endoplasmic reticulum calcium homeostasis.

International journal for parasitology. Drugs and drug resistance·2026
Same author

Bedaquiline inhibits the ATP synthase leak channel and prevents glutamate-induced neuronal death.

Biophysical reports·2026
Same author

Investigation of mitochondrial inner membrane ion conductance by planar lipid bilayer electrophysiology.

Frontiers in physiology·2026
Same author

Pd(II)-Catalyzed C-H Activation/<i>O</i>‑Annulation toward Succinimide-Embedded Tetracyclic Pyranonaphthoquinones and Their Application as Metal Sensors.

ACS omega·2026
Same journal

Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity.

Journal of medicinal chemistry·2026
Same journal

Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

Journal of medicinal chemistry·2026
Same journal

3',4'-Isopropylidene-α-galactosylceramide Enables Multidose Th1 Adjuvanticity Despite Limited Serial Serum IFN-γ Responsiveness.

Journal of medicinal chemistry·2026
Same journal

A Bioorthogonally Cleavable <i>N</i>-Oxide Linker for Prodrug Design: Elucidating the Structure-Cyclization Kinetics Relationships for Controlled Drug Release.

Journal of medicinal chemistry·2026
Same journal

A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

Journal of medicinal chemistry·2026
Same journal

Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

Journal of medicinal chemistry·2026
查看所有相关文章

相关实验视频

Updated: Jan 11, 2026

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

10.9K

作为单剂量治疗性抗疟疾药物的原产品优化.

Amrendra Kumar1, Yuexin Li2, Xiaowei Zhang2

  • 1Department of Chemistry, Portland State University, Portland, Oregon 97201, United States.

Journal of medicinal chemistry
|November 18, 2025
PubMed
概括
此摘要是机器生成的。

合成了新的原始类比物来对抗耐药疟疾. 化合物PG102在小鼠模型中显示出强烈的口服疗效,以及对具有低毒性的耐药疟疾菌株的活性.

更多相关视频

An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
12:02

An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity

Published on: November 2, 2016

12.5K
Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.8K

相关实验视频

Last Updated: Jan 11, 2026

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

10.9K
An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
12:02

An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity

Published on: November 2, 2016

12.5K
Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.8K

科学领域:

  • 药用化学 医学化学
  • 寄生虫学的寄生虫学
  • 药物发现 药物发现 药物发现

背景情况:

  • 耐药疟疾需要具有独特机制的新型抗疟疾药物.
  • 现有的治疗方法面临着新出现的抗药性挑战.
  • 多阶段活性和良好的耐受性是新抗疟疾药物的关键要求.

研究的目的:

  • 设计和合成新型原产品类似物作为潜在的抗疟疾药物.
  • 识别具有广泛活动阶段和有利安全概况的化合物.
  • 解决对抗耐药菌株有效的新抗疟疾药物的迫切需要.

主要方法:

  • 系统修改原始脚手架的B和C环.
  • 合成了54种新的原产品类似物.
  • 在 *Plasmodium yoelii* 和 *Plasmodium berghei* 的小鼠模型中进行了体内疗效测试.
  • 在体外测试对抗抗美西宁耐药的 *Plasmodium falciparum* 菌株.
  • 基因毒性和心脏毒性分析.

主要成果:

  • 化合物PG102 (类型6) 在红细胞疟疾模型中显示出治疗性口服疗效.
  • PG102提供了对肝脏阶段感染的保护,并保留了对抗耐药P. falciparum*的效力.
  • 该化合物具有中等的杀虫特征,具有低的基因毒性和心脏毒性潜力.
  • 在原始类中首次证明了强大的单剂量抗疟疾疗效.

结论:

  • PG102是下一代抗疟疾药物开发的有希望的化合物.
  • 原始的脚手架可以有效地修改,以产生强大的抗疟疾药物.
  • 由于其有效性和安全性,PG102的进一步开发需要进行调查.